QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文 2019, 卷号: 112, 页码: 57-65 作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan 收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03 Progression-free survival  Tolerability  Locally recurrent or metastatic breast cancer  Eribulin   MIRACLE study (CBCSG016): A randomized phase II study of letrozole versus letrozole plus everolimus for hormone receptor positive premenopausal women with recurrent or metastatic breast cancer on goserelin treatment after progession on tamoxifen. 期刊论文 2015, 卷号: 33, 期号: 15 作者:  Xu, Binghe;  Liu, Donggeng;  Lu, Jinsong;  Ouyang, Tao;  Li, Xiang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 MIRACLE study (CBCSG016): A randomized phase II study of letrozole versus letrozole plus everolimus for hormone receptor positive premenopausal women with recurrent or metastatic breast cancer on goserelin treatment after progession on tamoxifen. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  Xu, Binghe;  Liu, Donggeng;  Lu, Jinsong;  Ouyang, Tao;  Li, Xiang 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13 Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study 期刊论文 2012, 卷号: 125, 期号: 5, 页码: 764-769 作者:  Xu Bing-he;  Jiang Ze-fei;  Shen Zhen-zhou;  Guan Zhong-zhen;  Chen Zheng-dong 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 bevacizumab  metastatic breast cancer  angiogenesis  first-line  Chinese  docetaxel